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Human p&e& gty~~proteins fib a dIIIa form the receptor for fibrinogen, van Wilkbrand factor and Iibronectin. Isolated human 8I~cop~t~ins 
Ilb-IIIa are phospharylated by purified pp6oo”‘F protein tyrosine kinase. Analysis of the phosphorylated proteins on SDS-PAGE showed that under 
reducing conditions both phosphoproteins change their relative molecular masses from I35 to 120 kDa and from 97 to 105 kDa, which are charac- 
teristic properties of glycoproteins IIb-IIIa. Phosphorylated proteins could be immunoprecipitated with an antiserum against glycoproteins Klb-IIIa 
but not by control serum. Some kinetic properties of the glycoprotein phosphorylations are also investigated. How the glycoprotein IIb-IIIa complex 
acquires its receptor activity in stimulated platelets is unknown; however, phosphorylation could be an important mechanism. 
p~6oC-~; Protein tyrosine kinase; Glycoprotein 11% Glycoprotein IIIa; Integrin; (Platelet) 
Glycoproteins 1%Iffa (GP 1%IIIa) are two major 
integral membrane components in human blood 
platelets. They exist as a noncovalently associated 
asymmetrical complex requiring Ca” to maintain a 
heterodimeric structure [1,2]. The two giycaproteins 
belong to the integrin family (3) and the complex acts as 
a receptor for fibronectin, von Willebrand factor and 
fibrinogen [4]. In unstimulated platelets the GP IIb-IIIa 
complex does not bind to any of these ligands but the 
mechanism which controls the receptor activity is not 
understood. 
Here, we show that the isolated gly~oprotei~s IIb and 
flfa serve as substrates of purified ppdoE“” from 
human platelets. 
2. MATERIALS AND METHODS 
2.1. Materials 
Concavalin A-Sepharose (W-15 mg concavatin A/ml), heparin- 
agarose (800 fig heparIn/ml~~ Mops ~4-mo~hoiinepropa~~s~~fo~c 
acid), 0-phosphoserine and 0-phosphothreonine were purchased 
from Sigma, M&&en, FRG. Sephacryl S-300 was from Pharmacia, 
F&burg, FR 0-phosphotyrosine was prepared as in [9]. [r_“P] ATP 
13000 Ci/mmol, 1 Ci = 3.7 x IO’O Bq) was purchased from Amers- 
ham Buchler, Bra~scbweig, FRG. 
Platelets express high levels of pp60“‘“, which is the 
cellular homologue of the transforming protein of Rous 
sarcoma virus [5-71. pp60c-8’c represents he prototype 
of nontransmembrane normal protein tyrosine kinases 
(PTKs) of which the physiological function and regula- 
tion in platelets are still unknown. 
2.2, ~~~a~~o~ of ty~oprotei~~~b a ~~~aandp~-~~~rn human 
platelets 
Clinically outdated human piatelet concentrates (10-15 days after 
We have recently reported that pp60c~s” seems to be 
involved in tyrosine phosphorylation ofvarious platelet 
membrane proteins [8]. As the localisation and relative 
molecular masses of two of these proteins (105 and 120 
kDa) correspond under reducing conditions in SDS- 
PAGE analysis with the GP IIb and ifla of human 
platelets we studied the role of platelet pp60c-‘” FTK 
upon phospborylation of these glycoproteins. 
blood collection) wore obtained from the local blood bank. Platelets 
(log wet weight) wereisolated as described [8]. Glycoproteins lib-IIIa 
were purified according to Fitzgerald et al. [lo] with the following 
modifi~ons: (i) Concavalin A-Sepharose (25 ml) was ~~i~~brated 
with buffer A (10 mM TWHCI, 100 mM NaCI, 1 mM CaClz, &OS%, 
NaN3, 0.1% (v/v) Triton X-100, pH 7.4) additionally containing 1 
mM M&12. Before loading onto the concavalin A-Sepharose, the ex- 
tract (supernatant) was supplemented with 1 mM MnClz. The flow- 
through was again applied to the column. (ii) Instead of 
bep~n-~ph~o~, bep~n-arose (25 ml) was used. (iii) Sephacryl 
S-300 was packed into a cohurm with a diameter of 2 cm. Bed volume 
was 257 ml. 
pp60’~s’F PTK was purified according to 1’71 modified as described 
by Reuter et al. (submitted). 
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2.3. In vitro phosphorytation assay of glycoproteins Ub rend Ula 
A&brev~atia~: FTK, protein tyrosine kinase; pp60”““, the 60 kDa 
phosphoprotein encoded by the cellular (c-) src-gene; GP IIb-IIIa, 
glycoproteins IIb and IIIa; SDS-PAGE, SDS-potyacryiamtde g l elec- 
trophoresis 
The phosphotransferase assay was performed for 20 min at 30°C in 
a total volume of SO rJ containing 2 mM MgCl2.2 mM h&K&, various 
amounts of ~ycopr~teifls IIb and IIIa, purified PTK and ATP con- 
centrations as indicated and 25 mM Mops, pH 6.5. The reaction was 
terminated by addition of 20 $ SDS-sample buffer containing either 
10% 2-mercaptoethanol r none. The samples were analysed by SDS- 
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PAGE according to Laemmli [ 111. The dried gels were exposed to 
Kodak X-Omat films for autoradiography. Glycoproteins IIb-IIIa 
were cut out from the dried gels and radioactivity determined by 
Cerenkov counting. 
2.4. Immunoprecipitation of the phosphorylated glycoproteins IIb 
and IIIa 
For immunoprccipitation the phosphotransferase reaction was 
stopped by addition of neutralised EDTA (pH 7.0) and Nas Vo4 at 
final concentrations of 10 mM and 200 FM, respectively. Phos- 
phorylated GP IIb-IIIa (65 gg) was incubated with 10 ~1 GP IIb-IIIa 
antiserum or 10 d control serum for 1 h at 4’C. The immunocomplex 
was adsorbed onto swollen Protein A-Sepharose (4 mg dry weight per 
sample) for an additional 1.5 h at 4’C. The following steps were per- 
formed as described recently [ 121. 
2.5. Two-dimensional polyacrylamide gel electrophoresis 
Two-dimensional analysis of the phosphorylated proteins (isoelec- 
tric focusing and SDS-PAGE with 8% polyacrylamide gels in the se- 
cond dimension) was performed according to O’Farrel [13] with the 
BioRad mini gel system (Bio Rad, Miinchen, FRG). Ampholine 
reagents (Serva, Heidelberg, FRG) with pH 4-5 and 5-7 were used for 
isoelectric focusing. Reducing conditions were applied throughout. 
2.6. Analysis of phosphorylated amino acids 
Two-dimensional separation and identification of phosphoamino 
acids were performed according Hunter and Sefton [14]. 
2.7. Protein determination 
Protein was determined by the Coomassie dye-binding assay [ 151. 
3. RESULTS 
Intact pp60c-s” purified from human blood platelets 
[Reuter et al, submitted) phosphorylates the human GP 
IIb-IIIa. Two-dimensional separation of the phos- 
phorylated proteins under reducing conditions yields 
only two phosphoproteins of 120 and 105 kDa (fig.lA). 
This result excludes the possibility that the glycoprotein 
preparation was contaminated with other proteins of 
the same relative molecular masses which could also 
serve as substrates of the purified PTK. Both proteins 
are exclusively phosphorylated on tyrosine residues 
(fig. 1B). Densitometric analysis on the Coomassie 
stained gels sh6w that GP IIb-IIIa isolated according to 
Fitzgerald et al. [lo] form about 60% of total protein of 
the preparation. The ratio between glycoprotein IIb and 
IIIa was 1: 1 i The glycoprotein preparation did not 
show any endogenous kinase activity. 
Glycoprotein IIb consists of a large a-chain and a 
small P-chain linked by disulfide bonds. Glycoprotein 
IIIa, however, is a single polypeptide chain containing 
one or more intramolecular disulfide bond(s) [4]. 
Therefore, under reducing conditions both glycopro- 
teins typically change their electrophoretic mobility on 
SDS-PAGE. Analysis on SDS-PAGE revealed that 
both phosphorylated proteins apparently change their 
relative molecular masses in the presence of 
2-mercaptoethanol from 135 to 120 kDa and from 97 to 
105 kDa (fig.2A). The phosphoproteins on the resulting 
autoradiograms correspond with the Coomassie- 
stained bands. Furthermore, the phosphorylated pro- 
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Fig.1. (A) Tyrosine phosphorylation of 105 kDa and 120 kDa platelet 
proteins by purified pp60c~‘“. GP IIb-IIIa (28 fig) was phosphorylated 
in the presence of 180 ng purified PTK and 6 nM ATP. The 
phosphorylated proteins were analysed by two-dimensional gel elec- 
trophoresis. The autoradiogram of the phosphoproteins analysed by 
SDS-PAGE in the second dimension is shown (for details see section 
2). (B) Two dimensional phosphoamino acid analysis of the 105 kDa 
and 120 kDa phosphoproteins. Separation and identification of the 
phosphoamino acids were performed according to Hunter and Sefton 
[14]. The dashed circles show the positions of the standard 
phosphoamino acids identified by ninhydrin. y, phosphotyrosine; t,
phosphothreonine; s, phosphoserine; Pi, orthophosphate. 
teins could be immunoprecipitated by an antiserum 
against GP IIb-IIIa, but not by control serum (fig.2B). 
The titre of the antiserum was positive up to 1: 12 800 
on the ELISA test system. These data clearly show that 
the two proteins phosphorylated by purified pp60c+” 
PTK are the human platelet glycoproteins IIb-IIIa. The 
25 kDa P-chain of GP IIb is not phosphorylated. 
Phosphorylation of GP IIb-IIIa at 30°C was a linear 
time-dependent process completed within 30 min of in- 
cubation time (not shown). GP IIb and IIIa were 
phosphorylated by purified pp60c-SrC in a concentra- 
tion-dependent manner (fig.3). The Km values for GP 
IIb and GP IIIa were 1 and 0.75 PM, respectively. The 
K,,, value of ATP for phosphorylation of both 
glycoproteins was 4 pM (fig.4) and coincides with that 
of pp60c-src for casein phosphorylation [7; Reuter et al., 
submitted]. 
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Fig.2. Identity of the tyrosine phosphorylated 105 and 120 kDa pro- 
tein substrates of purified pfl” from human ptatelets. (A) isolated 
GP IIb-IIIa from human platelets (11 c(g) were phosphorylated by 70 
ng purified PTK in the presence of 1 ,&I ATP as described in section 
2. The proteins were analysed by SDS-PAGE in the absence (-) (2,4) 
or presence (+ ) of 2-mercaptoethanol(l,3). Coomassie stained pro- 
teins (1,2) and the autoradiograms of the corresponding “P-labeled 
proteins (3,4) are demonstrated. (B) The autoradiogram of the im- 
munopr~pitat~ and phospho~~ted proteins is shown. Isolated GP 
IIb-IIIa (384 pg) was phosphorylated by 200 ng purified PTK in the 
presence of 17 nM y-[“P]ATP. Immunoprecipitation of phosphory- 
lated proteins was performed as described in section 2. Lane 1, con- 
trol serum; 2, GP IIb-IIIa antiserum. 
4. DISCUSSION 
The C-SIX gene product, pp60c‘s” is expressed in high 
levels in human blood platelets 151. Platelets also 
possess high levels of total cell phosphotyrosine, which 
may in part be ascribed to pp60c”” protein tyrosine 
kinase activity [16]. However, the physioiogical func- 
tion of pp60c”‘E in mature cells like platelets is still 
unknown. 
We have recently reported that Zn2 + enhances 
tyrosine phosphorylation of various proteins in human 
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Fig.3. Substrate dependence of the glycoproteins IIb and IIIa 
phosphorylation by purified pp60c-sX. Samples containing 145 ng 
purified PTK, 1 FM ATP and various concentrations of GP IIb-IIIa 
were used in the assay performed as described in section 2. Enzyme 
activity is expressed as picomoles phosphate incorporated into the 
glycoproteins IIb and IIIa/min per mg ppW-sW. 
blood platelets membranes including proteins of 105 
and 120 kDa. These phosphorylation reactions were 
supressed after preincubation of the membranes with 
antibodies (TBR-IgG) which bind to pp6oc”” [8]. We 
now show that isolated ~ycoproteins IIb and IIIa of 
human platelets are substrates of purified intact 
pp60c-src PTK (figs 1 and 2). 
In intact platelets stimulation with the physiological 
agonist thrombin induces tyrosine phosphorylation of 
various proteins [ 16,171. Among these are two proteins 
with relative molecular masses of 105 kDa and 126 kDa. 
[ 171. In a recent report Ferrell and Martin [ 181 
demonstrated that the glycoproteins IIb-IIIa are involv- 
ed in regulation of platelet PTK activities. Inhibition of 
Fig.4. Dependence of glycoproteins IIb and IIIa phosphorylation on ATP. The experiment was performed in the presence of 0.45 pg isolated GP 
IIb and 0.4 pg GP IIIa, 145 ng purified PTK and various concentrations of ATP as described in section 2. The total volume was 50 d. The satura- 
tion curve is shown in (A). The data of (A) are presented as a double reciprocal plot in (B). 
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ligand binding to GP IIb-IIIa inhibits the thrombin-in- 
duced tyrosine phosphorylation of 126, 130, 108 and 
100 kDa proteins. However, it has not yet been studied 
whether any of these substrates could be GP IIb-IIIa. 
The cytoplasmic domain of GP IIIa has a tyrosine 
residue, which shows sequence homology with 
phosphorylation sites of insulin and epidermal growth 
factor receptors associated with transmembrane PTKs 
[4]* In chicken embryonic fibroblasts transformed by 
oncogenes coding for PTRs (v-src, v-yes, v-fps, v-erbB) 
bands 2 and 3 of the fibronectin receptor complex 
become phosphorylated at tyrosine residues [19]. The 
avian fibronectin receptor complex (CSAT antigen) and 
the platelet GP Ifb-IIIa complex belong to the cell sur- 
face proteins of the integrin family. The members of the 
integrin family are transmembr~e ~lycopr~~ins which 
link extracellular matrix proteins to the cytoskeleton 
[ZO]. How the stimulation-dependent receptor function 
of GP IIb-IIIa is regulated is unknown, but 
phospho~lation could be an important mechanism, 
The thromb~-induct phospho~lat~on f pp6@-” at 
Ser-12 and Tyr-527 seems not to influence its kinase ac- 
tivity [17]. But it is not excluded that these phosphoryla- 
tions alter the substrate accessability of pp60c-s” or its 
localisation. Therefore, the possible role of pp60c-sre in 
regulation of the receptor activity of GP IIb-IIIa re- 
mains an interesting field for further i~vest~at~ons. 
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